title: What new immunotherapeutic techniques are currently being investigated for the treatment of melanoma?
authors.forename: Oliver G
authors.initials: OG
authors.lastname: Donnelly
authors.forename: Alan A
authors.initials: AA
authors.lastname: Melcher
authors.forename: Richard G
authors.initials: RG
authors.lastname: Vile
authors.forename: Jose
authors.initials: J
authors.lastname: Pulido
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D005818:Genetic Engineering; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007211:Indoles / Q000627:therapeutic use*; D000074324:Ipilimumab; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D058990:Molecular Targeted Therapy; D050130:Oncolytic Virotherapy; D057285:Precision Medicine; D012878:Skin Neoplasms / Q000276:immunology / Q000628:therapy*; D013449:Sulfonamides / Q000627:therapeutic use*; D000077484:Vemurafenib
chemical_list: D000911:Antibodies, Monoclonal; D007211:Indoles; D000074324:Ipilimumab; D013449:Sulfonamides; D000077484:Vemurafenib